Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED

NCT02713789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction

Interventions

DRUG: hMaxi-K Single Treatment/ 2 escalating dose levels (8000 µg and 16000 µg injection)
DRUG: Placebo (PBS-20% sucrose)

Sponsor

Urovant Sciences GmbH

Collaborators

[object Object]
[object Object]